A Study to Confirm the Efficacy and Safety of Different Dupilumab Dose Regimens in Adults With Atopic Dermatitis (AD)
Clinical trial NCT02395133 · COMPLETED
Trial details
- NCT number
- NCT02395133
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-25
- Primary completion
- 2016-07-01
- Enrollment
- 422
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.